Login to Your Account



Pieris, Daiichi Sankyo Ink Anticalins Deal for up to $296M

By Cormac Sheridan


Wednesday, April 13, 2011
Pieris AG is banking €7 million (US$10.1 million) up front and could earn up to €200 million more in milestone payments and research funding from a discovery deal with Daiichi Sankyo, based around its anticalin protein scaffold technology. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription